Stay updated on Uproleselan with Chemotherapy for AML Clinical Trial
Sign up to get notified when there's something new on the Uproleselan with Chemotherapy for AML Clinical Trial page.

Latest updates to the Uproleselan with Chemotherapy for AML Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoNo Change Detected
- Check18 days agoChange DetectedRevision: v3.5.0 is now shown, replacing the previous Revision: v3.4.3.SummaryDifference0.0%

- Check25 days agoChange DetectedRevision updated from v3.4.2 to v3.4.3. This appears to be a minor site maintenance update with no changes to study data or content.SummaryDifference0.0%

- Check54 days agoChange DetectedThe page now displays Revision: v3.4.2 and removes the earlier government-funding notices and Revision: v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check61 days agoChange DetectedAdded a site-wide notice about a lapse in government funding and NIH Clinical Center status. Updated the page revision from v3.4.0 to v3.4.1.SummaryDifference0.3%

- Check68 days agoChange DetectedThe page now shows a glossary toggle, and updates to labels such as 'Last Update Submitted that Met QC Criteria', 'No FEAR Act Data', and the revision note to v3.4.0, which are formatting and metadata changes rather than changes to the study details themselves. There are no changes to core study content, eligibility, endpoints, or primary conclusions. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check82 days agoChange DetectedRevision updated from v3.3.3 to v3.3.4. No substantive study details appear to be affected.SummaryDifference0.0%

Stay in the know with updates to Uproleselan with Chemotherapy for AML Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Uproleselan with Chemotherapy for AML Clinical Trial page.